U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3318133181Tiemann Mounted Urodynamic Catheter Technique for Difficult Bladder CatheterizationCompletedNo Results AvailableURINATION DISORDERSDevice: INSERTION OF URETEHRL CATHETERhttps://ClinicalTrials.gov/show/NCT02130843
3318233182Topical Anesthesia Versus Placebo to Decrease Pain in Rubber Band Ligation for Treatment of Internal HemorrhoidsRecruitingNo Results AvailableHemorrhoids|PainDrug: Topical 2,5% lidocaine + 2,5% prilocaine gel|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02130830
3318333183Belatacept in Kidney Transplantation of Moderately Sensitized PatientsRecruitingNo Results AvailableEnd Stage Renal Disease|Antibody Mediated RejectionDrug: Belatacept|Drug: Tacrolimus withdrawal|Procedure: Plasmapheresis/Intravenous Immunoglobulin G|Drug: Thymoglobulin (ATG)|Drug: Myfortic|Drug: Steroidshttps://ClinicalTrials.gov/show/NCT02130817
3318433184Using Salsalate to Target Adipocyte Macrophage InfiltrationCompletedNo Results AvailableDiabetes RiskDrug: Salsalate (4 g/day)|Drug: Placebo (4 g/day)https://ClinicalTrials.gov/show/NCT02130804
3318533185Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep LossRecruitingNo Results AvailableSleep Restriction Then Total Sleep Deprivation|Total Sleep Deprivation Then Sleep RestrictionBehavioral: Sleephttps://ClinicalTrials.gov/show/NCT02130791
3318633186Natriuretic Effect of GLP-1in Healthy Non Obese SubjectsRecruitingNo Results AvailableSodium Excretion by UrinationDrug: Synthetic GLP-1 (1.5 pmol/kg/min) dissolved in 500 ml 0.9% salinehttps://ClinicalTrials.gov/show/NCT02130778
3318733187Substrate Targeted Ablation Using the FlexAbilityâ„¢ Ablation Catheter System for the Reduction of Ventricular TachycardiaRecruitingNo Results AvailableMonomorphic Ventricular TachycardiaDevice: Cardiac catheter ablation with ICD/CRT-Dhttps://ClinicalTrials.gov/show/NCT02130765
3318833188Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma SurgeryNot yet recruitingNo Results AvailableGastric Cancer|Surgery|Ultrasonic Scalpel|Monopolar Electrocautery|Operation Time|Blood Loss, Surgical|Quality of Life|External Causes of Morbidity and MortalityDevice: Monopolar electrocautery|Device: Ultrasonic scalpelhttps://ClinicalTrials.gov/show/NCT02130752
3318933189Horner's SD After Thoracic Epidural BlockCompletedNo Results AvailableHorner's SyndromeProcedure: thoracic epidural anesthesia|Procedure: mastectomy|Drug: Ropivacaine|Drug: Propofol|Drug: Fentanylhttps://ClinicalTrials.gov/show/NCT02130739
3319033190Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapyRecruitingNo Results AvailableGastric CancerProcedure: Minimally-invasive gastrectomy|Procedure: Open Gastrectomyhttps://ClinicalTrials.gov/show/NCT02130726
3319133191Treatment of Chronic Bacterial ProstatitisCompletedNo Results AvailableChronic Bacterial ProstatitisDrug: Third generation fluoroquinolone|Dietary Supplement: Nutritional supplement + third generation fluoroquinolonehttps://ClinicalTrials.gov/show/NCT02130713
3319233192Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With EnzalutamideRecruitingNo Results AvailableProstate CancerDrug: VT-464: given orally twice daily in 28-day cycleshttps://ClinicalTrials.gov/show/NCT02130700
3319333193Effect of Chronic ACE and DPP4 Inhibition on Blood PressureRecruitingNo Results AvailableType 2 Diabetes Mellitus|HypertensionDrug: Placebo|Drug: Sitagliptin|Drug: Aprepitant|Other: Mixed Meal Test (MMT)https://ClinicalTrials.gov/show/NCT02130687
3319433194Optimized Therapy in Severe Traumatic Brain Injured PatientsCompletedNo Results AvailableTraumatic Brain Injury|ComaDrug: Dipeptivenhttps://ClinicalTrials.gov/show/NCT02130674
3319533195Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy VolunteersNot yet recruitingNo Results AvailableAlzheimer's DiseaseDrug: Rilapladib 25 mg|Drug: Rilapladib 250 mg|Drug: Itraconazolehttps://ClinicalTrials.gov/show/NCT02130661
3319633196Non Ivasive Prenatal Diagnosis (NIPD) of Cystic FibrosisRecruitingNo Results AvailableNoninvasive Mucinous Cystadenocarcinoma of OvaryOther: A sampling of bloodhttps://ClinicalTrials.gov/show/NCT02130648
3319733197A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: GSK2269577 1000 mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02130635
3319833198Study of Promethazine for Treatment of Diabetic GastroparesisRecruitingNo Results AvailableDiabetic GastroparesisDrug: Promethazine|Drug: Sugar pillhttps://ClinicalTrials.gov/show/NCT02130622
3319933199Skintel Integration StudyActive, not recruitingNo Results AvailableSkin Type From I-VI on Non-hair Bearing SkinDevice: Skintelhttps://ClinicalTrials.gov/show/NCT02130609
3320033200An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic IllnessCompletedNo Results AvailablePsychotic IllnessesBehavioral: Acceptance-Based Behavioral Intervention|Other: Nutritional Counsellinghttps://ClinicalTrials.gov/show/NCT02130596
3320133201Skills to Enhance Positive Affect in Suicidal AdolescentsRecruitingNo Results AvailableSuicide IdeationBehavioral: Positive Affect Skills Training|Behavioral: Treatment as Usualhttps://ClinicalTrials.gov/show/NCT02130583
3320233202Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care TransitionsRecruitingNo Results AvailableAdverse Events|Readmissions|Patient EngagementOther: Multi-Model Intensive Discharge Interventionhttps://ClinicalTrials.gov/show/NCT02130570
3320333203A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaActive, not recruitingNo Results AvailableLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveDrug: Bosutinib|Drug: Imatinibhttps://ClinicalTrials.gov/show/NCT02130557
3320433204Acute Pain Management Following Video-assisted Thoracoscopic Surgery: Comparison of Lobectomy and Wedge ResectionRecruitingNo Results AvailablePostoperative Painhttps://ClinicalTrials.gov/show/NCT02130544
3320533205Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationActive, not recruitingNo Results AvailableGeographic Atrophy|Age-Related Macular DegenerationDrug: Emixustat HCl Tablet|Other: Placebo Tablethttps://ClinicalTrials.gov/show/NCT02130531
3320633206Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter PatencyRecruitingNo Results AvailableUrinary Catheter Blockage and EncrustationDrug: Auriclosene Irrigation Solution, 0.2%|Drug: Auriclosene Vehicle Solutionhttps://ClinicalTrials.gov/show/NCT02130518
3320733207Inflammatory Aspects of Glucose in Hyperlipidemia and DiabetesCompletedNo Results AvailableAtherosclerosis|Leukocyte Activation Disorder|Type 2 Diabetes Mellitus|Familial Combined HyperlipidemiaDietary Supplement: OGTThttps://ClinicalTrials.gov/show/NCT02130505
3320833208A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)RecruitingNo Results AvailableRadiosensitive Stage IV Solid and Hematological Tumors With High FDG Uptake Not Responding to Standard of Care|Lung Cancer, Head and Neck Cancer, Breast Cancer, Gastric Cancer, Pancreatic Cancer, Colon Cancer, Lymphomas, Sarcomas, EtcRadiation: FDGhttps://ClinicalTrials.gov/show/NCT02130492
3320933209Testing a Promising Treatment for Youth Substance Abuse in a Community SettingRecruitingNo Results AvailableSubstance Abuse|Delinquency|Mental HealthBehavioral: Contingency Management-Family Engagement|Behavioral: Treatment as Usualhttps://ClinicalTrials.gov/show/NCT02130479
3321033210A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)RecruitingNo Results AvailableMelanomaBiological: Pembrolizumab|Drug: Dabrafenib|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT02130466

* Görseller ve İçerik tekif hakkına sahip olabilir